Literature DB >> 17464512

Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.

Simone Schmid1, Milos Opravil, Michael Moddel, Milo Huber, Rahel Pfammatter, Gerald Keusch, Patrice Ambuhl, Rudolf P Wuthrich, Holger Moch, Zsuzsanna Varga.   

Abstract

We performed a retrospective analysis on kidney biopsies of 30 human immunodeficiency virus (HIV)-positive patients. Twenty-two of them received highly active antiretroviral therapy (HAART). Tenofovir containing HAART together with atazanavir, a new protease inhibitor, was administered to three patients. All of them developed acute renal failure. The kidney biopsies of these patients showed an acute interstitial nephritis or a chronic interstitial nephritis with an acute component. Withdrawal of atazanavir and tenofovir resulted in recovery of renal function in all three patients. Acute interstitial nephritis was observed only in 1 of 19 patients without atazanavir or tenofovir treatment. We conclude that acute interstitial nephritis and consecutive acute renal failure is a relevant side effect of atazanavir and tenofovir therapy in HIV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464512     DOI: 10.1007/s00428-007-0418-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  Serious renal impairment occurs rarely with use of tenofovir DF.

Authors:  James D Scott; Peter R Wolfe; Robert K Bolan; Bill Guyer
Journal:  HIV Clin Trials       Date:  2006 Mar-Apr

Review 2.  Renal pathology of human immunodeficiency virus infection.

Authors:  V D'Agati; G B Appel
Journal:  Semin Nephrol       Date:  1998-07       Impact factor: 5.299

3.  Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.

Authors:  Alexandre Karras; Matthieu Lafaurie; André Furco; Anne Bourgarit; Dominique Droz; Daniel Sereni; Christophe Legendre; Frank Martinez; Jean-Michel Molina
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

4.  Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.

Authors:  Gerald Friedland; Laurie Andrews; Tanya Schreibman; Sangeeta Agarwala; Leith Daley; Michael Child; Julia Shi; Yonghua Wang; Edward O'Mara
Journal:  AIDS       Date:  2005-10-14       Impact factor: 4.177

5.  [Acute tubulointerstitial nephritis in HIV infection].

Authors:  M Möddel; R Pfammatter; Z Varga; G Keusch
Journal:  Praxis (Bern 1994)       Date:  2006-06-07

Review 6.  HIV and the kidney: a status report after 20 years.

Authors:  Monique E Cho; Jeffrey B Kopp
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

Review 7.  Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.

Authors:  Christina M Wyatt; Paul E Klotman
Journal:  Expert Opin Drug Saf       Date:  2006-03       Impact factor: 4.250

8.  Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy.

Authors:  S Hailemariam; M Walder; H R Burger; G Cathomas; M Mihatsch; U Binswanger; P M Ambühl
Journal:  Swiss Med Wkly       Date:  2001-07-14       Impact factor: 2.193

9.  Acute interstitial nephritis associated with atazanavir, a new protease inhibitor.

Authors:  Ursula C Brewster; Mark A Perazella
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

10.  HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism.

Authors:  Roy J Kim; Camella G Wilson; Martin Wabitsch; Mitchell A Lazar; Claire M Steppan
Journal:  Obesity (Silver Spring)       Date:  2006-06       Impact factor: 5.002

View more
  18 in total

1.  Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis.

Authors:  Shyam M Parkhie; Derek M Fine; Gregory M Lucas; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

Review 2.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 3.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

4.  Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir.

Authors:  Alana Brennan; Denise Evans; Mhairi Maskew; Saraladevi Naicker; Prudence Ive; Ian Sanne; Thapelo Maotoe; Matthew Fox
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

Review 5.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 6.  Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients.

Authors:  Minoru Ando; Naoki Yanagisawa
Journal:  World J Nephrol       Date:  2015-07-06

7.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

8.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

Review 9.  Atazanavir: its role in HIV treatment.

Authors:  Robin Wood
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

10.  Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.

Authors:  Ying Cao; Yang Han; Jing Xie; Qu Cui; Lixia Zhang; Yijia Li; Yanling Li; Xiaojing Song; Ting Zhu; Taisheng Li
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.